Načítá se...
Characterization of designed, synthetically accessible bryostatin analog HIV latency reversing agents
HIV latency in resting CD4+ T cell represents a key barrier preventing cure of the infection with antiretroviral drugs alone. Latency reversing agents (LRAs) can activate HIV expression in latently infected cells, potentially leading to their elimination through virus-mediated cytopathic effects, ho...
Uloženo v:
| Vydáno v: | Virology |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Academic Press
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6018613/ https://ncbi.nlm.nih.gov/pubmed/29800728 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.virol.2018.05.006 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|